EUVIMEDEUVIMED entdecken
Crossref

The epigenetic EZH2/H3K27me3 axis modulates lactotroph tumor cell proliferation

N Zlocowski iD, L D V Sosa, B De la Cruz-Thea, C B Guido, M G Martín, J H Mukdsi, A I Torres, J P Petiti

Journal of Endocrinology · 2023

DOI: 10.1530/joe-22-0195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, 2023. Verfasst von N Zlocowski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Microscopía Electrónica, Facultad de Ciencias Médicas (CME-FCM) - Instituto de Investigaciones en Ciencias de la Salud, Consejo Nacional de…. Hauptthemen laut MEDLINE: Lactotrophs, Pituitary Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interest in epigenetics has gained substantial momentum as a result of their identified role in the regulation of tumor progression as well as their ability to pharmacologically target genes. Pituitary neuroendocrine tumors (PitNETs) tend to be inactivated via epigenetic modification, and although emerging evidence has suggested a role for epigenetic factors in PitNET tumorigenesis, the degree to which these factors may be targeted by new therapeutic strategies still remains poorly understood. The objective of the present study was to examine the participation of the EZH2/H3K27me3 axis in the proliferation of lactotroph tumor cells. We demonstrated that the levels of EZH2 and H3K27me3 were increased in murine experimental prolactin (PRL) tumors with respect to a control pituitary, in contrast with the low p21 mRNA levels encountered, with an H3K27me3 enrichment being observed in its promoter region in a GH3 tumor cell. Furthermore, specific EZH2/H3K27me3 axis inhibition blocked the proliferation of primary tumor cell culture and GH3 cells, thereby making it an attractive therapeutic target for PRL PitNETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactotrophsPituitary NeoplasmsNeuroendocrine TumorsHumansMiceAnimalsHistonesEnhancer of Zeste Homolog 2 ProteinCell Line, TumorEpigenesis, GeneticCell Proliferation

Stichwörter der Autor:innen

EZH2GSK343H3K27me3PRL tumor

Substanzen

HistonesEnhancer of Zeste Homolog 2 ProteinEZH2 protein, human

Autor:innen und Institutionen

  • Centro de Microscopía Electrónica, Facultad de Ciencias Médicas (CME-FCM) - Instituto de Investigaciones en Ciencias de la Salud, Consejo Nacional de Investigaciones Científicas Técnicas (INICSA-CONICET), Universidad Na…
  • Cellular and Molecular Neurobiology Department, CONICET - Universidad Nacional de Córdoba - Instituto de Investigación Médica Mercedes y Martín Ferreyra, Córdoba, Argentina.

ORCID-Profile: N Zlocowski

Zitieren

APA

Zlocowski, N., Sosa, L. D. V., De la Cruz-Thea, B., Guido, C. B., Martín, M. G., Mukdsi, J. H., Torres, A. I., & Petiti, J. P. (2023). The epigenetic EZH2/H3K27me3 axis modulates lactotroph tumor cell proliferation. Journal of Endocrinology. https://doi.org/10.1530/joe-22-0195

Vancouver

Zlocowski N, Sosa LDV, De la Cruz-Thea B, Guido CB, Martín MG, Mukdsi JH, et al. The epigenetic EZH2/H3K27me3 axis modulates lactotroph tumor cell proliferation. Journal of Endocrinology. 2023. doi:10.1530/joe-22-0195

BibTeX
@article{Zlocowski2023,
  author = {Zlocowski, N and Sosa, L D V and De la Cruz-Thea, B and Guido, C B and Martín, M G and Mukdsi, J H and Torres, A I and Petiti, J P},
  title = {The epigenetic EZH2/H3K27me3 axis modulates lactotroph tumor cell proliferation},
  journal = {Journal of Endocrinology},
  year = {2023},
  doi = {10.1530/joe-22-0195}
}
Kostenlos starten →